Chair, Department of Medicine
Mount Sinai Beth Israel
Professor of Medicine and Vice-Chair, Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York
Ira M. Jacobson, MD, has disclosed that that he has served as a consultant or on advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Intercept, Janssen, Merck, and Trek; has served on speaker bureaus for AbbVie, Gilead Sciences, Intercept and Merck; and has received funds for research support from AbbVie, Gilead Sciences, Genfit, and Merck.
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Stefan Zeuzem, MD, has disclosed that he has served as a consultant or on advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Roche.
Associate Scientific Director
Director, Scientific Services
This program is intended for physicians including infectious diseases specialists, hepatologists, and gastroenterologists, registered nurses, and other healthcare professionals involved in the care of patients with liver disease.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 contact hour may be earned for successful completion of this activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 01, 2017, through January 31, 2018:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
CCO faculty Paul Kwo, MD, answers FAQs in hepatitis B management including treatment candidacy and duration
Audio from CCO faculty Dr. Nancy Reau on strategies to address gaps in viral hepatitis care: learn how to prevent HAV and HBV, how to screen for and treat HCV
Hear CCO faculty Brent A. Neuschwander-Tetri, MD, explore NASH screening and interplay between NAFLD, metabolic syndrome, CV risk, diabetes risk
Downloadable slides on data from AALSD 2019 selected by expert faculty as relevant to care of patients with viral hepatitis or NAFLD/NASH, as reported by Clinical Care Options.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.